Digital Health Frontier Blog

By John Halamka and Paul Cerrato - Despite some skepticism about the usefulness of AI in clinical medicine, there’s ample evidence to show CAD-assisted colonoscopy can save lives.

By John Halamka • October 27, 2022

By John Halamka and Paul Cerrato - It’s not about fame and fortune.

By John Halamka • October 20, 2022

By John Halamka and Paul Cerrato - AI-enabled algorithms can’t exist in an operational vacuum. To really benefit our patients, they need to be deployed with the help of an interprofessional team of experts and a set of “delivery science” principles that most developers are not aware of.

By John Halamka • October 12, 2022

By John Halamka and Paul Cerrato - The latest proposed rules from CMS and FDA emphasize the need for a balanced, nuanced approach to digital innovation.

By John Halamka • October 7, 2022

By John Halamka and Paul Cerrato - Challenging the status quo in technology and medicine can take a heavy toll, but history has demonstrated that it often yields measurable benefits for both clinicians and patients.

By John Halamka • September 29, 2022

By John Halamka and Paul Cerrato - Smartphone-based applications may help detect atrial fibrillation, warn clinicians about worsening mental status, and improve the management of heart failure.

By John Halamka • September 22, 2022

By John Halamka and Paul Cerrato - Every clinician knows that early detection is one of the most powerful tools we have in the war on cancer. Several computational tools are enabling us to make early detection a reality, at least in two specialties.

By John Halamka • September 15, 2022

By John Halamka and Paul Cerrato - Two recent studies strongly suggest that sepsis predictive algorithms may in fact be ready for “prime time.”

By John Halamka • August 31, 2022

By John Halamka and Paul Cerrato - A recent report points out that providers are not taking the necessary steps to secure the mobile devices connected to their network.

By John Halamka • August 25, 2022

By John Halamka and Paul Cerrato - A growing number of studies show that drug/gene interactions can influence how patients respond to specific medications. But there are barriers that prevent the full implementation of pharmacogenomic testing into routine clinical practice.

By John Halamka • August 18, 2022